Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy.
Schmitz M, Temme A, Senner V, Ebner R, Schwind S, Stevanovic S, Wehner R, Schackert G, Schackert HK, Fussel M, Bachmann M, Rieber EP, Weigle B.
Schmitz M, et al. Among authors: stevanovic s.
Br J Cancer. 2007 Apr 23;96(8):1293-301. doi: 10.1038/sj.bjc.6603696. Epub 2007 Mar 20.
Br J Cancer. 2007.
PMID: 17375044
Free PMC article.